Bharat biotech’s COVID-19 vaccine Covaxin gets DCGI nod for phase 3 clinical trial, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The vaccine ‘Covaxin’ is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)., The vaccine ‘Covaxin’ is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)., , Read More

Leave a Reply

Your email address will not be published.